Shandong Sinobioway Biomedicine Company Description

Shandong Sinobioway Biomedicine Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates in China.

The company manufactures and supplies trimethyl orthoformate, triethyl orthoformate, trimethyl orthoacetate, phosphorous acid, ethyl formate, and trimethyl acetate and its by-products.

It also offers Anfulan, a human interferon α2b injection; Jiefu, a human interferon α2b spray; Enjingfu, a mouse nerve growth factor for injection; and Bellaph, a combined hepatitis A and B vaccine.

In addition, the company is involved in biopharmaceutical research and development services, including cell line development and cell bank building, cell culture process development, protein purification process development, preparation prescription and process development, analysis and detection method development, and quality research.

Further, it provides biopharmaceutical production services, such as preclinical, clinical phase I/II/III and commercial manufacturing; and other services, including regulatory service support and drug registration affairs.

Shandong Sinobioway Biomedicine Co., Ltd. was founded in 2000 and is based in Shenzhen, China. Shandong Sinobioway Biomedicine Co., Ltd. is the subsidiary of Shenzhen Yilian Technology Co., Ltd.

Shandong Sinobioway Biomedicine Co., Ltd.

Country	China
Founded	2000
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	507
CEO	Jialin Yue

Contact Details

Address: Room 2005, No. 22 Shenzhen, 518057 China
Phone	86 75 5869 50185
Website	sinobiowaymed.com.cn

Stock Details

Ticker Symbol	002581
Exchange	Shenzhen Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE1000012Y5
SIC Code	2833

Key Executives

Name	Position
Jialin Yue	Chairman and GM
Wenjun Liu	Deputy GM and Non-Independent Director
Hui Zhao	Board Secretary and Employee Director
Wenyu Zhang	Deputy General Manager
Ren Yanshen	Co-Founder
Chen Zhangliang	Co-Founder